Myalgic Encephalomyelitis: Clinical Trials

1 trial for Myalgic Encephalomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Myalgic Encephalomyelitis: new trials by email Literature Review of Myalgic Encephalomyelitis trials Research Report on Myalgic Encephalomyelitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Solriamfetol Oral Tablet [Sunosi], Placebo - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 4CompletedRochester Center for Behavioral Medicine442021-04-272025-04-06

Narrower conditions

Fatigue Syndrome, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Encephalomyelitis (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

solriamfetol (1)

Sponsors

Rochester Center for Behavioral Medicine (1)

Countries

United States (1)

Top investigators

Joel Young, MD (1)

Results publications

PMID 40958377